| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.4 | 0.005 |